Glucan, a folded high-molecular-weight polysaccharide, has multiple ef
fects in animals when administered intravenously or intraperitoneally,
but not when administered by inhalation. The hypotheses tested were w
hether intratracheal administration of glucan can cause lung damage an
d whether some of the resulting lung injury is immunologically mediate
d. There was a dose-response relationship between the amount of intrat
racheally injected glucan and the extent of pulmonary histologic abnor
malities, which consisted of peribronchiolar and intraalveolar infiltr
ation with chronic inflammatory cells. An attempt to adoptively transf
er increased susceptibility to glucan induced lung injury was made. Ce
lls cultured with glucan were transferred into naive recipients before
intratracheal glucan exposure. The extent of pulmonary inflammation t
hat occurred as a result of intratracheal injection of glucan was not
affected by transfer of cultured cells from glucan-treated animals. Ho
wever, high concentrations of glucan in culture did produce cells with
the appearance of lymphoblasts. These data indicate that glucan induc
es lung injury, but that there is no evidence of cell mediation of pul
monary injury induced by intratracheal exposure to glucan.